482 related articles for article (PubMed ID: 29756288)
1. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Verdolini N; Hidalgo-Mazzei D; Murru A; Pacchiarotti I; Samalin L; Young AH; Vieta E; Carvalho AF
Acta Psychiatr Scand; 2018 Sep; 138(3):196-222. PubMed ID: 29756288
[TBL] [Abstract][Full Text] [Related]
2. Treating mixed mania/hypomania: a review and synthesis of the evidence.
Takeshima M
CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
5. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder.
Grunze H; Vieta E; Goodwin GM; Bowden C; Licht RW; Azorin JM; Yatham L; Mosolov S; Möller HJ; Kasper S;
World J Biol Psychiatry; 2018 Feb; 19(1):2-58. PubMed ID: 29098925
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
7. The treatment of mixed states and the risk of switching to depression.
Vieta E
Eur Psychiatry; 2005 Mar; 20(2):96-100. PubMed ID: 15797692
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
Geoffroy PA; Bellivier F; Henry C
Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the recognition and management of mixed depression.
Stahl SM; Morrissette DA; Faedda G; Fava M; Goldberg JF; Keck PE; Lee Y; Malhi G; Marangoni C; McElroy SL; Ostacher M; Rosenblat JD; Solé E; Suppes T; Takeshima M; Thase ME; Vieta E; Young A; Zimmerman M; McIntyre RS
CNS Spectr; 2017 Apr; 22(2):203-219. PubMed ID: 28421980
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
Fountoulakis KN; Kasper S; Andreassen O; Blier P; Okasha A; Severus E; Versiani M; Tandon R; Möller HJ; Vieta E
Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262 Suppl 1():1-48. PubMed ID: 22622948
[TBL] [Abstract][Full Text] [Related]
12. Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Sakuma K; Okuya M; Matsuda Y; Esumi S; Hashimoto Y; Hatano M; Miyake N; Miura I; Mishima K; Iwata N
Bipolar Disord; 2021 Dec; 23(8):789-800. PubMed ID: 33561884
[TBL] [Abstract][Full Text] [Related]
13. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of mixed states.
Cuomo A; Nikolova VL; Yalin N; Arnone D; Fagiolini A; Young AH
CNS Spectr; 2017 Apr; 22(2):186-195. PubMed ID: 28416033
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
16. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M
Bipolar Disord; 2018 Mar; 20(2):97-170. PubMed ID: 29536616
[TBL] [Abstract][Full Text] [Related]
17. New treatment guidelines for acute bipolar mania: a critical review.
Nivoli AM; Murru A; Goikolea JM; Crespo JM; Montes JM; González-Pinto A; García-Portilla P; Bobes J; Sáiz-Ruiz J; Vieta E
J Affect Disord; 2012 Oct; 140(2):125-41. PubMed ID: 22100133
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
Nair SS; Chua CJM; Teo DCL
East Asian Arch Psychiatry; 2021 Sep; 31(3):81-83. PubMed ID: 34588318
[TBL] [Abstract][Full Text] [Related]
19. Drug treatments for bipolar disorder: 1--Acute manic or depressive episodes.
Drug Ther Bull; 2005 Apr; 43(4):28-32. PubMed ID: 15849974
[TBL] [Abstract][Full Text] [Related]
20. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
